Skip to main content
. Author manuscript; available in PMC: 2011 Jul 30.
Published in final edited form as: Brain Res. 2010 May 27;1346:174–182. doi: 10.1016/j.brainres.2010.05.063

Figure 4. Short-term atipamezole leads to recovery of motor performance in ladder rung walking after permanent MCAO regardless of physical rehabilitation.

Figure 4

End point analysis – At eight weeks following MCAO, ladder walk performance following ATI/REHAB was significantly better than either vehicle-treated group (*, p<0.05, two-way ANOVA followed by Student-Newman-Keuls). A two-way repeated measures ANOVA indicated that the ATI/CON and ATI/REHAB groups achieved end-point performance that was not different from pre-operative levels while both vehicle-treatment groups still displayed significant deficits when compared to pre-operative performance (+, p<0.05, Student-Newman-Keuls). Data represent the mean ± SEM for following number of animals/group: VEH/CON = 9, VEH/REHAB = 9, ATI/CON = 9, ATI/REHAB = 10.